Table 1 Baseline event rates used in the economic evaluation
Baseline incidence | Point estimate | Low | High |
|---|---|---|---|
Placebo event rates (Tunçalp [14]) | |||
PPH | 16.0 % | 12.0 % | 27.3 % |
Severe PPH | 3.0 % | 0.7 % | 9.7 % |
Additional uterotonics | 7.2 % | 0.7 % | 38.7 % |
Blood transfusion | 0.8 % | 0.5 % | 0.9 % |
Shivering | 10.8 % | 0.0 % | 17.3 % |
Fever | 1.6 % | 0.0 % | 4.3 % |
Oxytocin event rates (Tunçalp [14]) | |||
PPH | 12.4 % | 0.4 % | 17.3 % |
Severe PPH | 2.7 % | 0.0 % | 6.5 % |
Additional uterotonics | 11.1 % | 4.4 % | 14.0 % |
Blood transfusion | 1.1 % | 0.0 % | 1.6 % |
Shivering | 6.0 % | 0.0 % | 40.4 % |
Fever | 1.0 % | 0.00 % | 7.00 % |
Placebo event rates; alternative values: home birth setting (Hundley [23]) | |||
PPH | 12.2 % | NC | NC |
Severe PPH | 1.2 % | NC | NC |
Additional uterotonics | 5.4 % | NC | NC |
Blood transfusion | 2.9 % | NC | NC |
Shivering | 17.8 % | NC | NC |
Fever | 13.8 % | NC | NC |